Early Diagnosis of Acute Lymphoblastic Leukemia Using YOLOv8 and YOLOv11 Deep Learning Models
Alaa Awad, Salah A. Aly
TL;DR
The paper addresses early detection of Acute Lymphoblastic Leukemia (ALL) from multi-cell blood smear images by applying transfer learning with YOLOv8 and YOLOv11 on a fused two-class Normal vs Cancer dataset derived from ALL image datasets. It employs HSV-based OpenCV segmentation, mosaic and other augmentations, and explores multiple optimizers with 50 training epochs to achieve high accuracy. Key contributions include first use of YOLOv11 for ALL detection, demonstration of strong cross-dataset generalization, and competitive accuracy up to 98.8% under certain configurations, surpassing several prior CNN-based approaches. The work demonstrates potential for robust, real-world ALL screening across diverse samples including hematogones, supporting faster and more reliable clinical decision-making.
Abstract
Leukemia, a severe form of blood cancer, claims thousands of lives each year. This study focuses on the detection of Acute Lymphoblastic Leukemia (ALL) using advanced image processing and deep learning techniques. By leveraging recent advancements in artificial intelligence, the research evaluates the reliability of these methods in practical, real-world scenarios. Specifically, it examines the performance of state-of-the-art YOLO models, including YOLOv8 and YOLOv11, to distinguish between malignant and benign white blood cells and accurately identify different stages of ALL, including early stages. Moreover, the models demonstrate the ability to detect hematogones, which are frequently misclassified as ALL. With accuracy rates reaching 98.8%, this study highlights the potential of these algorithms to provide robust and precise leukemia detection across diverse datasets and conditions.
